Robert Philibert
Director Técnico/Científico/I+D en CARDIO DIAGNOSTICS HOLDINGS, INC. .
Fortuna: 1 M $ al 31/05/2024
Cargos activos de Robert Philibert
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Director/Miembro de la Junta | 25/10/2022 | - |
| Director Técnico/Científico/I+D | 25/10/2022 | - | |
Cardio Diagnostics, Inc.
 Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Director/Miembro de la Junta | 01/05/2017 | - |
| Fundador | 01/05/2017 | - | |
| Corporate Officer/Principal | 01/05/2017 | - | |
| University of Iowa | Corporate Officer/Principal | 01/01/1998 | - |
Historial de carrera de Robert Philibert
Antiguos cargos conocidos de Robert Philibert.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Behavioral Diagnostics, LLC | Fundador | 01/01/2009 | - |
Formación de Robert Philibert.
| University of Iowa | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director/Board Member | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Consumer Services | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
| Behavioral Diagnostics, LLC |
- Bolsa de valores
- Insiders
- Robert Philibert
- Experiencia
